Last reviewed · How we verify
Test Vaccine Vi-DT Typhoid conjugate — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Test Vaccine Vi-DT Typhoid conjugate (Test Vaccine Vi-DT Typhoid conjugate) — International Vaccine Institute. Vi-DT Typhoid conjugate vaccine stimulates the immune system to produce antibodies against Salmonella Typhi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Test Vaccine Vi-DT Typhoid conjugate TARGET | Test Vaccine Vi-DT Typhoid conjugate | International Vaccine Institute | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Test Vaccine Vi-DT Typhoid conjugate CI watch — RSS
- Test Vaccine Vi-DT Typhoid conjugate CI watch — Atom
- Test Vaccine Vi-DT Typhoid conjugate CI watch — JSON
- Test Vaccine Vi-DT Typhoid conjugate alone — RSS
Cite this brief
Drug Landscape (2026). Test Vaccine Vi-DT Typhoid conjugate — Competitive Intelligence Brief. https://druglandscape.com/ci/test-vaccine-vi-dt-typhoid-conjugate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab